8e4f | pdb_00008e4f

Crystal structure of dihydrofolate reductase (DHFR) from the filarial nematode W. bancrofti in complex with NADPH and folate

spinqualitylabelsall models 8e4f, resolution 2.47Å Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Structural highlights 8e4f is a 1 chain structure with sequence from Wuchereria bancrofti. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance. Ligands: FOL, NA, NAP Resources: FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT Function J9F199_WUCBA Publication Abstract from PubMed Lymphatic filariasis is a debilitating illness with an estimated 50 million cases as of 2018. The majority of cases are caused by the parasitic worm W. bancrofti and additional cases by the worms B. malayi and B. timori. Dihydrofolate reductase (DHFR) is an established target in the treatment of cancer, bacterial, and protozoal infections and may be a potential target for drugs targeting parasitic worm infections, including filariasis. Recent studies have shown that known antifolate compounds, including methotrexate, inhibit the activity of W. bancrofti DHFR (WbDHFR). However, the absence of structural information for filarial DHFRs has limited the study of more in-depth structure-function relationships. We report the structure of WbDHFR complexed with NADPH and folate using X-ray diffraction data measured to 2.47 A resolution. The structure of WbDHFR reveals the usual DHFR fold and is currently only the second nematode DHFR structure in the Protein Data Bank. The equilibrium dissociation constants for NADPH (90 +/- 29 nM) and folate (23 +/- 4 nM) were determined by equilibrium titrations. The interactions of known antifolates with WbDHFR were analyzed using molecular docking programs and molecular dynamics simulations. Antifolates with a hydrophobic core and extended linker formed favorable interactions with WbDHFR. These combined data should now facilitate the rational design of filarial DHFR inhibitors, which in turn can be used to determine whether DHFR is a viable drug target for filariasis and whether existing antifolates may be repurposed for its treatment. Crystal structure of dihydrofolate reductase from the filarial nematode W. bancrofti in complex with NADPH and folate.,Lange K, Frey KM, Eck T, Janson CA, Gubler U, Goodey NM PLoS Negl Trop Dis. 2023 Apr 27;17(4):e0011303. doi: , 10.1371/journal.pntd.0011303. PMID:37104530 From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Proteopedia Page Contributors and Editors (what is this?)

OCA